CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a Phase 3 prospective, randomized, superiority, open-label, multi-site study. The overview of this study is as follows:* A Screening/Baseline...
Phase 3
Valhalla, New York, United States and 2 other locations
Glioblastoma (GBM) adaptive, global, innovative learning environment (GBM AGILE) is an international, seamless Phase II/II....
Phase 2, Phase 3
New Haven, Connecticut, United States and 62 other locations
The purpose of this study is to assess progression-free survival (PFS) and overall survival (OS) in newly diagnosed Glioblastoma (GBM...
Phase 2
Valhalla, New York, United States and 22 other locations
(TMZ) in adult participants with newly-diagnosed, MGMT unmethylated glioblastoma multiforme (GBM). The main question it aims to ans...
Phase 3
Guilford, Connecticut, United States and 94 other locations
This clinical trial is testing the safety and efficacy of NanO2TM administered via intravenous infusion in combination with standard radiation and ch...
Phase 2
New Haven, Connecticut, United States and 11 other locations
Clinical trials
Research sites
Resources
Legal